• Home
• Our Services
  • Early Phases
  • Late Phases
  • Biometrics
    • Data Management
    • Bio-Statistics
    • Pharmacovigilance
    • Pharmacoeconomics
  • Regulatory
  • Bio-Equivalence
  • Resourcing
  • Commercialization
  • Risk Sharing
  • Innovative Solutions
• News & Events
• About us
  • Company History
  • Corporate Leadership
• Contact us
  • How to contact us
  • How we can help you!
  • Where we can help you!
• Partners
  • DCRC
  • CEE-RI
  • Maximax International
  • Maximax Venture

MPR launches early phase clinical research capabilities in Michigan, USA.

:: HOME :: CONTACT US ::	COPYRIGHT MPR DEVELOPMENT GROUP 2002-

01-10-2007: Warren, Michigan.

MPR launches early phase clinical research capabilities in Michigan, USA. The new business unit will be lead by several of the Company executives and cover a proposal to set up a 50-bed unit in Troy Michigan. The early phase business unit launched also a joint venture with St. John Health System to partner in supporting early phase clinical trials in several of St. John Health facilities in Michigan including a proposal to transfer the Detroit Riverview medical facility into a research lab and clinical research unit.

The main focus of the partnership project is to support patient-volunteer based studies and focus on Oncology. The project aims also to partner with leading Health Institutions in Michigan such as Karmanos Cancer Institute, University of Michigan and several others.